Bristol Myers Squibb's strong Q3 driven by soaring demand for Opdivo, Reblozyl, Breyanzi and Camzyos pushes shares up 7.2% in ...
Subcutaneous injections of an investigational, selective long-acting amylin receptor agonist led to clinically meaningful ...
UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM ESTCompany ParticipantsAndrew Dickinson - Chief ...
Johnson & Johnson ( JNJ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 11, 2025 10:30 AM EST ...
What prompted a lifetime in stitches? Not the humorous kind - the painful sort. Was it worth it or, as that unsisterly ...
November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025HighlightsAnnouncement of Genmab’s proposed ...
Eli Lilly and Company’s LLY stock has risen 18% in a month, driven mainly by a stellar third-quarter performance. Also, ...
NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Every company reaches a turning point when its technology stops being promise and starts becoming structure. SMX is there now. The company that gave ...
Multiple myeloma remains an incurable blood cancer, with nearly all patients relapsing and requiring subsequent therapy ...
November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025 Highlights Announcement of Genmab's proposed acquisition of Merus N.V. (Merus)Genmab revenue increased ...
A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.
By preparing for events of indulgence by exercising and moving more on days we know we’re going to indulge in copious amounts ...